These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37786919)

  • 21. Selective Chemical Labeling Strategy for Oligonucleotides Determination: A First Application to Full-Range Profiling of Transfer RNA Modifications.
    Zhang HX; Qin JF; Sun JF; Pan Y; Yan TM; Wang CY; Bai LP; Zhu GY; Jiang ZH; Zhang W
    Anal Chem; 2023 Jan; 95(2):686-694. PubMed ID: 36601728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multifaceted roles of mass spectrometric analysis in nucleic acids drug discovery and development.
    Kenderdine T; Fabris D
    Mass Spectrom Rev; 2023; 42(4):1332-1357. PubMed ID: 34939674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A High-Throughput Workflow for Mass Spectrometry Analysis of Nucleic Acids by Nanoflow Desalting.
    Lanzillotti MB; Brodbelt JS
    Anal Chem; 2024 Feb; ():. PubMed ID: 38330443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease Diagnosis Based on Nucleic Acid Modifications.
    Xue X; Wang Z; Wang Y; Zhou X
    ACS Chem Biol; 2023 Oct; 18(10):2114-2127. PubMed ID: 37527510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with German Research Consortia in the Field of Chemical Biology of Native Nucleic Acid Modifications.
    Helm M; Bohnsack MT; Carell T; Dalpke A; Entian KD; Ehrenhofer-Murray A; Ficner R; Hammann C; Höbartner C; Jäschke A; Jeltsch A; Kaiser S; Klassen R; Leidel SA; Marx A; Mörl M; Meier JC; Meister G; Rentmeister A; Rodnina M; Roignant JY; Schaffrath R; Stadler P; Stafforst T
    ACS Chem Biol; 2023 Dec; 18(12):2441-2449. PubMed ID: 37962075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contributions of mass spectrometry in the study of nucleic acid-binding proteins and of nucleic acid-protein interactions.
    Rusconi F; Guillonneau F; Praseuth D
    Mass Spectrom Rev; 2002; 21(5):305-48. PubMed ID: 12645088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Molecule Detection of Nucleic Acids via Liposome Signal Amplification in Mass Spectrometry.
    Lin X; Zhao M; Li M; Long J; Zhang J; Yu F; Xu F; Sun L
    Sensors (Basel); 2022 Feb; 22(4):. PubMed ID: 35214249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass Spectrometry for Investigating the Effects of Toxic Metals on Nucleic Acid Modifications.
    Xiong J; Yuan BF; Feng YQ
    Chem Res Toxicol; 2019 May; 32(5):808-819. PubMed ID: 30920205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of nearest neighbors in nucleic acids by mass spectrometry.
    Rozenski J; McCloskey JA
    Anal Chem; 1999 Apr; 71(7):1454-9. PubMed ID: 10204043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometry in the biology of RNA and its modifications.
    Giessing AM; Kirpekar F
    J Proteomics; 2012 Jun; 75(12):3434-49. PubMed ID: 22348820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of RNA Hydroxylmethylation in Mammals by Mass Spectrometry Analysis.
    You XJ; Liu T; Ma CJ; Qi CB; Tong Y; Zhao X; Yuan BF; Feng YQ
    Anal Chem; 2019 Aug; 91(16):10477-10483. PubMed ID: 31318193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress and trends on the analysis of nucleic acid and its modification.
    Ouyang J; Zhan X; Guo S; Cai S; Lei J; Zeng S; Yu L
    J Pharm Biomed Anal; 2020 Nov; 191():113589. PubMed ID: 32942104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of protein-nucleic acid interactions by photochemical cross-linking and mass spectrometry.
    Steen H; Jensen ON
    Mass Spectrom Rev; 2002; 21(3):163-82. PubMed ID: 12476441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MS analysis of nucleic acids in the post-genomic era.
    Fabris D
    Anal Chem; 2011 Aug; 83(15):5810-6. PubMed ID: 21651236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the Influence of Nucleic Acid Backbone Modifications on Lipid Nanoparticle Morphology.
    An K; Kurek D; Mahadeo M; Zhang Y; Thewalt JL; Cullis PR; Kulkarni JA
    Langmuir; 2022 Nov; 38(46):14036-14043. PubMed ID: 36367350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultraviolet Photodissociation and Activated Electron Photodetachment Mass Spectrometry for Top-Down Sequencing of Modified Oligoribonucleotides.
    Santos IC; Lanzillotti M; Shilov I; Basanta-Sanchez M; Roushan A; Lawler R; Tang W; Bern M; Brodbelt JS
    J Am Soc Mass Spectrom; 2022 Mar; 33(3):510-520. PubMed ID: 35157441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids.
    Meek KN; Rangel AE; Heemstra JM
    Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions targeted at oxidatively generated modifications of nucleic acids focused on urine and plasma markers.
    Larsen EL; Weimann A; Poulsen HE
    Free Radic Biol Med; 2019 Dec; 145():256-283. PubMed ID: 31563634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of mass spectrometry in genomics.
    Meng Z; Simmons-Willis TA; Limbach PA
    Biomol Eng; 2004 Jan; 21(1):1-13. PubMed ID: 14715314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.